SEC Form 4 · accession 0001209191-18-049247
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Financial · Other
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | M | 8,743 | $2.0864 | A | 44,238 | D | |
| Common Stock | Aug 30, 2018 | M | 4,007 | $5.5004 | A | 48,245 | D | |
| Common Stock | Aug 30, 2018 | M | 7,250 | $24.47 | A | 55,495 | D | |
| Common StockF2 | Aug 30, 2018 | S | 19,022 | $175.365 | D | 36,473 | D | |
| Common StockF3 | Aug 30, 2018 | S | 978 | $176.0273 | D | 35,495 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $2.0864 | Aug 30, 2018 | M | 8,743 | D | — | Jul 13, 2021 | Common Stock | 8,743 | 0 | D |
| Stock Option (right to buy)F5 | $5.5004 | Aug 30, 2018 | M | 4,007 | D | — | Jan 16, 2023 | Common Stock | 4,007 | 0 | D |
| Stock Option (right to buy)F6 | $24.47 | Aug 30, 2018 | M | 7,250 | D | — | Mar 3, 2024 | Common Stock | 7,250 | 25,021 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- F2The range of prices for the transaction reported on this line was $175.00 to $175.95. The average weighted price was $175.365. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $176.00 to $176.20. The average weighted price was $176.0273. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4This option vested over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.
- F5This option to purchase shares of our common stock was granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013 and April 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014 and April 1, 2014, respectively, with the remainder of the shares vesting in equal monthly installments over the following three years.
- F6This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.